Urosource: Headline News

Urosource Newsletter

Poll

Home > Headline News

Today's Key Article

Conference Reports

Reovirus works against prostate cancer tumours

Edited by: JV

Thursday, 11 March 2010- A virus that destroys cancer cells but leaves normal cells unharmed works against prostate cancer, according to a study conducted by Canadian researchers.

The virus also blasts lymphoid, colon, ovarian, breast, pancreatic, brain, lung, head and neck, and other cancer...

Interactive

ASCO: PCA3 test assessed in two studies

Thursday, 11 March 2010- Researchers involved in the international Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial have reported that the urinary PCA3 test can predict biopsy outcome in men taking dutasteride. The details of two studies were presented at the 2010 American Society...

Edited by: ES

Specialist can influence treatment choice of elderly men with localised PCa

Wednesday, 10 March 2010- A new study published in the latest issue of the Archives of Internal Medicine by an investigator at The Cancer Institute of New Jersey (CINJ) and colleagues at Memorial Sloan-Kettering Cancer Center in New York, showed that the type of specialist consulted by elderly men...

Edited by: JV

More key articles

BENEFIT: belatacept preserves kidneys, avoids toxicity

Monday, 8 March 2010- The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.

The results are published in...

Circulating endothelial cells and progenitors: potential RCC biomarkers

Friday, 5 March 2010- A group of Australian researchers compared the levels of circulating endothelial cells (CECs) and progenitors (CEPs) between tumour-bearing mice and healthy controls, in human renal cell carcinoma (RCC) xenograft models.

B. Namdarian and colleagues said they also aimed...

More headline news

Drinking alcohol raises PCa risk in African-Americans

Wednesday, 10 March 2010- Alcohol consumption may be associated with an increased risk of prostate cancer in African-American men, according to researchers.

A team led by Lionel L. Bañez, Assistant Professor of Medicine at Duke University Medical Center in Durham, N.C., prospectively collected...

Death after prostatectomy seldom due to prostate cancer

Tuesday, 9 March 2010- Cumulative mortality from prostate cancer 15 years after radical prostatectomy is six times lower than death from other causes, according to study findings presented at the Genitourinary Cancers Symposium. Among men older than 65 years at the time of surgery, cumulative...

More conference reports

Most skeletal-related events due to bony metastases

Tuesday, 8 March 2010- Skeletal-related events (SREs) in patients with metastatic hormone-refractory prostate cancer (mHRPC) are mostly due to bony metastatic disease and not decreased bone mineral density (BMD), according to British researchers.

A study by Dr. Nicholas D. James, of The University...

Role of mechanical simulators for training of laparoscopic surgery

Friday, 19 February 2010- Low fidelity simulators will play an important role in the future with regards to laparoscopic surgical training in urology, according to Prof. Jens Rassweiler (Heilbronn, Germany), director of the hands-on training in laparoscopy offered during the recently concluded 19th...

7th ESOU Meeting in Vienna to tackle emerging treatment options

Friday, 8 January 2010- Emerging treatment options that impact on the diagnosis of uro-genital cancers will be examined at the annual meeting of the EAU Section of Oncological Urology (ESOU) to be held in Vienna, Austria from January 15 to 17, 2010.

Prof. Bob Djavan, chairman of the 7th ESOU...

2nd EMUC to reach new heights of international cooperation

Thursday, 26 November 2009- Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is a result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next...